Patents-Review.com
ClassID:

111529 ⎘

C12N2770/32334 - CPC Classification

Classification description:

ssRNA viruses positive-sense; Details; Picornaviridae; Enterovirus Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Recent Application in this class:
#1
20260069673
2026-03-12

BIVALENT INACTIVATED EV71-CA16 VACCINE, METHOD FOR PREPARING THE SAME, AND USE THEREOF

 #2
20250352634
2025-11-20

Coxsackievirus B Compositions and Methods Of Use Thereof

 #3
20250134983
2025-05-01

VIRAL VECTOR DELIVERY SYSTEM FOR BOTH RESPIRATORY AND DIGESTIVE TRACTS OF PIGS AND APPLICATION THEREOF

 #4
20240408189
2024-12-12

MULTI-CBV VACCINE FOR PREVENTING OR TREATING TYPE I DIABETES

 #5
20240261386
2024-08-08

Coxsackievirus 83 Vaccine

 #6
20230190911
2023-06-22

VACCINE FORMULATIONS WITH INCREASED STABILITY

 #7
20230174953
2023-06-08

DEFECTIVE INTERFERING VIRAL GENOMES

 #8
20220347295
2022-11-03

Vaccine delivery method

 #9
20210220465
2021-07-22

Multi-CBV vaccine for preventing or treating type I diabetes

 #10
20210023196
2021-01-28

Multi-CBV vaccine for preventing or treating type 1 diabetes

 #11
20210015916
2021-01-21

Vaccine delivery method

 #12
20200317739
2020-10-08

Recombinant polypeptides derived from FBP1 and FBP2 and uses of the same

 #13
20200000908
2020-01-02

Multi-CBV vaccine for preventing or treating type I diabetes

 #14
20190275136
2019-09-12

VACCINE FORMULATIONS WITH INCREASED STABILITY

 #15
20190240314
2019-08-08

Purification of recombinant EV71 virus-like particle and method for preparing vaccine thereof

 #16
20190224304
2019-07-25

CHIMERIC ENTEROVIRUS VIRUS-LIKE PARTICLES

 #17
20190209675
2019-07-11

Multi-CBV vaccine for preventing or treating type I diabetes

 #18
20190076519
2019-03-14

Immunogenic rhinovirus peptides

 #19
20180305422
2018-10-25

Recombinant polypeptides derived from FBP1 and FBP2 and uses of the same

 #20
20180271971
2018-09-27

Antigens and vaccines directed against human enteroviruses

 #21
20180243400
2018-08-30

Antigens and vaccines directed against human enteroviruses

 #22
20180214538
2018-08-02

Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus

 #23
20180195048
2018-07-12

METHODS FOR PRODUCING VIRUS FOR VACCINE PRODUCTION

 #24
20180187165
2018-07-05

Hand, foot, and mouth vaccines and methods of manufacture and use thereof

 #25
20180169215
2018-06-21

Multivalent enterovirus vaccine compositions and uses related thereto

 #26
20180125965
2018-05-10

Hand, foot, and mouth vaccines and methods of manufacture and use thereof

 #27
20180104324
2018-04-19

Immunogenic composition

 #28
20180008689
2018-01-11

RNA virus attenuation by alteration of mutational robustness and sequence space

 #29
20170348411
2017-12-07

Methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof

 #30
20170281748
2017-10-05

Multi-CBV vaccine for preventing or treating type I diabetes

 #31
20170202958
2017-07-20

VACCINE DELIVERY METHOD

 #32
20170151319
2017-06-01

Immunogenic composition for modulating the immune system and methods to treat bacterial infections in a subject

 #33
20170056491
2017-03-02

Adenoviral vector-based vaccine against enterovirus infection

 #34
20160271242
2016-09-22

Subunit vaccine platform based on multimeric ribonucleoproteins comprising nucleoproteins of a non-segmented negative-strand RNA virus as carriers of heterologous polypeptides

 #35
20160185826
2016-06-30

VIRUS-LIKE PARTICLE VACCINES

 #36
20160166675
2016-06-16

EV71 virus-like particles and preparation method and application thereof

 #37
20160129104
2016-05-12

Hand, foot, and mouth vaccines and methods of manufacture and use thereof

 #38
20160022803
2016-01-28

Vaccine

 #39
20150224204
2015-08-13

Immunogenic composition

 #40
20150224185
2015-08-13

Immunogenic compositions

 #41
20150140027
2015-05-21

Antigens and vaccines directed against human enteroviruses

 #42
20150056244
2015-02-26

Antigens and Vaccines Directed Against Human Enteroviruses

 #43
20150037355
2015-02-05

Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus

 #44
20140356962
2014-12-04

NOVEL ATTENUATED POLIOVIRUS: PV-1 MONO-CRE-X

 #45
20130243809
2013-09-19

Recombinant flaviviral constructs and uses thereof

 #46
20130084306
2013-04-04

Vaccines comprising cholesterol and CpG as sole adjuvant-carrier molecules

 #47
20120177686
2012-07-12

VACCINE FOR THE PREVENTION OF ACUTE LYMPHOBLASTIC LEUKEMIA

 #48
20120045468
2012-02-23

Immunogenic compositions and uses thereof

 #49
20120003240
2012-01-05

Enterovirus Vaccines for Preventing or Treating Type 1 Diabetes (III)

 #50
20120003239
2012-01-05

Enterovirus Vaccines for Preventing and Treating Type 1 Diabetes (II)

 #51
20120003238
2012-01-05

Enterovirus Vaccines for Preventing or Treating Type 1 Diabetes (I)

 #52
20110002943
2011-01-06

USE OF ENTEROVIRUS FOR DIAGNOSTICS, TREATMENT AND PREVENTION OF DISEASE

 #53
20080286308
2008-11-20

Pathogenic Bovine Enterovirus, Vaccines, and Diagnostic Methods

 #54
20060240466
2006-10-26

Prevention of type 1 diabetes and other non-polio enterovirus diseases